These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30466437)

  • 1. Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.
    Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Hou L; Murphy RL; Adewole IF; Simon MA
    BMC Health Serv Res; 2018 Nov; 18(1):885. PubMed ID: 30466437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV status, age at cervical Cancer screening and cervical cytology outcomes in an opportunistic screening setting in Nigeria: a 10-year Cross sectional data analysis.
    Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Silas O; Sagay AS; Anorlu R; Mehta SD; Wehbe F; Simon MA; Adewole IF; Hou L; Murphy RL
    Infect Agent Cancer; 2019; 14():43. PubMed ID: 31798680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
    Magaji FA; Mashor MI; Anzaku SA; Hinjari AR; Cosmas NT; Kwaghe BV; Ali JM; Christian EN; Sagay AS; Chandler A; Khan I; Murphy RL; Hou L; Musa J
    BMC Public Health; 2024 Jan; 24(1):193. PubMed ID: 38229083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
    Vigneshwaran E; Goruntla N; Bommireddy BR; Mantargi MJS; Mopuri B; Thammisetty DP; Veerabhadrappa KV; Bukke SPN
    BMC Cancer; 2023 Dec; 23(1):1216. PubMed ID: 38066496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Cervical Cancer Screening Service Utilization Among HIV-Positive Women Aged 25 Years and Above Attending Adult ART Clinics in Southern Tigray, Ethiopia.
    Gebrekirstos LG; Gebremedhin MH; Tafesse TT; Tura TS; Geleso MG; Wube TB
    Cancer Control; 2022; 29():10732748221126944. PubMed ID: 36112936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with utilization of cervical cancer screening services among HIV-positive women aged 18 to 49 years at Lira regional referral hospital, Northern Uganda.
    Layet F; Murungi T; Ashaba N; Kigongo E; Opollo MS
    BMC Womens Health; 2024 Feb; 24(1):114. PubMed ID: 38347497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of opportunistic cervical cancer screening in Nigeria.
    Habila MA; Sagay E; Obeng-Kusi M; Ali MJ; Magaji FA; Shambe IH; Daru PH; Jacobs ET; Madhivanan P; Sagay AS; Musa J
    Cancer Causes Control; 2024 Jan; 35(1):9-20. PubMed ID: 37530986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge about cervical cancer and barriers toward cervical cancer screening among HIV-positive women attending public health centers in Addis Ababa city, Ethiopia.
    Shiferaw S; Addissie A; Gizaw M; Hirpa S; Ayele W; Getachew S; Kantelhardt EJ; Assefa M; Jemal A
    Cancer Med; 2018 Mar; 7(3):903-912. PubMed ID: 29441700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
    Tron L; Lert F; Spire B; Dray-Spira R;
    HIV Med; 2017 Mar; 18(3):181-195. PubMed ID: 28967199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities, Hawassa town, Ethiopia: a cross-sectional study.
    Assefa AA; Astawesegn FH; Eshetu B
    BMC Health Serv Res; 2019 Nov; 19(1):847. PubMed ID: 31744548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unmet cancer screening need of HIV-positive women in southeastern Nigeria.
    Dim CC; Dim NR; Ezegwui HU; Ikeme AC
    Medscape J Med; 2009; 11(1):19. PubMed ID: 19295940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need to incorporate routine cervical cancer counselling and screening in the management of HIV positive women in Nigeria.
    Rabiu KA; Akinbami AA; Adewunmi AA; Akinola OI; Wright KO
    Asian Pac J Cancer Prev; 2011; 12(5):1211-4. PubMed ID: 21875269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer risk and screening among women seeking assistance with basic needs.
    Kuroki LM; Massad LS; Woolfolk C; Thompson T; McQueen A; Kreuter MW
    Am J Obstet Gynecol; 2021 Apr; 224(4):368.e1-368.e8. PubMed ID: 33316278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria.
    Habila MA; Obeng-Kusi M; Ali MJ; Magaji FA; Shambe IH; Daru PH; Jacobs ET; Madhivanan P; Sagay AS; Musa J
    BMC Womens Health; 2023 Nov; 23(1):640. PubMed ID: 38037005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening service utilisation and related factors among women on antiretroviral therapy in public health facilities of Asella town, Ethiopia, cross-sectional study.
    Yasin S; Ferede A; Tafa M
    BMC Infect Dis; 2024 Oct; 24(1):1115. PubMed ID: 39375613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of cervical cancer screening and its associated factors among women of child-bearing age in Mangochi district, Malawi: a facility-based cross-sectional study.
    Mpachika-Mfipa F; Kululanga LI; Mfipa D; Kazembe A
    BMC Womens Health; 2023 Jun; 23(1):334. PubMed ID: 37355588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening among women with comorbidities: evidence from the 2022 Tanzania demographic and health survey.
    Okyere J; Ayebeng C; Dosoo AK; Dickson KS
    BMC Public Health; 2024 Apr; 24(1):1093. PubMed ID: 38641602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening among women ≥70 years of age in the United States-A referral problem or patient choice.
    Guo F; Hirth JM; Berenson AB
    Prev Med; 2015 Dec; 81():427-32. PubMed ID: 26500084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data.
    Zhang D; Advani S; Huchko M; Braithwaite D
    BMJ Open; 2020 Jan; 10(1):e031823. PubMed ID: 31911515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.